New cancer clinical trial: Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Published on: February 27, 2018 at 12:00PM
Condition:   Neoplasms
Interventions:   Drug: GSK1795091;   Drug: GSK3174998
Sponsors:   GlaxoSmithKline;   IQVIA
Not yet recruiting
http://ift.tt/2F0aWqx